A resolution expressing support for the designation of July 2026 as "National Sarcoma Awareness Month".

119th Congress Introduced by Ron Johnson and 1 co-sponsor

The bill designates July 2026 as National Sarcoma Awareness Month to publicly promote sarcoma awareness and support through education and outreach (no funding).

Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent.

Summary of Bill: SRES 765 (Session 119)

Purpose and intent

SRES 765 is a concurrent or Senate-initiated resolution expressing support for designating July 2026 as National Sarcoma Awareness Month.

The resolution signals the United States Senate’s endorsement of efforts to raise awareness about sarcoma, a group of cancers arising in connective tissues.

Key provisions and changes

Declaration of support: The bill explicitly expresses the Senate’s support for proclaiming July 2026 as National Sarcoma Awareness Month.

Purpose of designation: While the resolution itself does not create new federal programs or funding, it aligns the Senate with awareness, education, and outreach efforts related to sarcoma.

Preamble and formal language: The resolution includes a preamble that provides context and justification for recognizing sarcoma awareness.

Who or what is affected

Public awareness: The designation targets the general public, patients, caregivers, researchers, healthcare providers, and advocacy groups by promoting awareness of sarcoma.

Federal messaging: The resolution communicates the Senate’s support to federal agencies, healthcare organizations, and the public, potentially influencing national-level awareness campaigns and public health messaging.

No funding or new authority: The resolution does not authorize new spending or expand federal programs; it is a symbolic measure expressing congressional support.

Procedural and timeline aspects

Consideration and passage: The resolution was submitted in the Senate on June 9, 2026, considered, and agreed to without amendment and with a preamble by Unanimous Consent.

Final status: Passed/agreed to in the Senate via Unanimous Consent on June 9, 2026.

Sponsors: Co-sponsors include Senators Ron Johnson and Mike Rounds.

Context and implications

Symbolic policy tool: As a resolution, the measure serves to acknowledge the importance of sarcoma awareness and may bolster advocacy and educational efforts without altering law or budget.

Potential impact: May enhance visibility for sarcoma research, patient resources, and nationwide campaigns during July 2026, potentially encouraging organizations to host events, fundraise, or disseminate information.

If you’d like, I can add context on typical effects of awareness-month designations and compare similar resolutions for other diseases.